Anzeige
Mehr »
Montag, 27.10.2025 - Börsentäglich über 12.000 News
Automatisierung ist das neue Gold: Telescope Innovations erfindet Entdeckung von Medizin & Materialien neu!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma Dive

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
11.09.Child dies in Capsida study of rare disease gene therapy
11.09.FDA shares guidance to drugmakers developing non-opioid pain medicines
10.09.FDA clears J&J's drug-device combo for bladder cancer
10.09.Kriya, Odyssey secure 'megarounds'; Amgen boosts R&D leadership
10.09.Novo Nordisk to lay off 9,000 workers in major restructuring
10.09.[Podcast] The Progress Profile: Alzheimer's Research in Focus
09.09.Lilly to give biotech startups access to AI tools
09.09.Novartis to gain heart drug in $1.4B deal for Tourmaline Bio
09.09.BioNTech says dual-acting lung cancer drug helped shrink tumors
08.09.A new class of sleep drugs draws Wall Street's attention
08.09.Pfizer, BioNTech showcase new data supporting COVID booster
08.09.New Summit data clouds approval pathway in lung cancer
08.09.Rapport shares double on better-than-expected seizure drug data
08.09.A UK biotech takes aim at Parkinson's, ALS by drugging mitochondria
08.09.Driving precision oncology development: Integrated biomarker testing solutions that deliver impact
08.09.How sponsors are staying ahead in the obesity trial landscape
08.09.Harnessing the power of AI to detect ATTR-CM
05.09.FDA to publish CRLs in real time; PEPFAR to distribute Gilead's Yeztugo
05.09.Bravehart, a stealthy startup, looks to China to challenge Bristol Myers heart drug
04.09.At Senate hearing, lawmakers express dissatisfaction with RFK Jr.'s vaccine moves
04.09.Atlas Venture reels in $400M to grow its biotech startups
04.09.FDA outlines new review pathway for drugs treating ultra-rare diseases
04.09.Sanofi's touted eczema drug hits study goal, but data fall short of expectations
04.09.A drug discovery startup banks $150M for immune and obesity drugs
03.09.Biohaven's rare disease drug is 'ready to ship on Day 1' following FDA approval